Showing results (61-70 of 762) with videos related to

Sort By:
Pageof 77
Journal of the American Society of Nephrology : JASN|January 5, 2000
Chronic proteinuric nephropathies. II. Outcomes and response to treatment in a prospective cohort of 352 patients: differences between women and men in relation to the ACE gene polymorphism. Gruppo Italiano di Studi Epidemologici in Nefrologia (Gisen)Piero Ruggenenti, Annalisa Perna, Carmine Zoccali, et al.
Kidney International|May 20, 2004
Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathyAriela Benigni, Elena Gagliardini, Susanna Tomasoni, et al.
Expert Opinion on Emerging Drugs|November 3, 2005
Emerging drugs for diabetic nephropathySimona Bruno, Dario Cattaneo, Norberto Perico, et al.
Journal of the American Society of Nephrology : JASN|June 24, 2003
Rituximab in idiopathic membranous nephropathy: a one-year prospective studyPiero Ruggenenti, Carlos Chiurchiu, Varusca Brusegan, et al.
Nephron. Clinical Practice|June 9, 2005
Cyclosporine prolongs delayed graft function in kidney transplantation: are rabbit anti-human thymocyte globulins the answer?Paolo Cravedi, Igor Codreanu, Antonio Satta, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Rituximab for idiopathic membranous nephropathy: who can benefit?Piero Ruggenenti, Carlos Chiurchiu, Mauro Abbate, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 27, 2010
Reducing polycystic liver volume in ADPKD: effects of somatostatin analogue octreotideAnna Caroli, Luca Antiga, Mariateresa Cafaro, et al.
Kidney International. Supplement|July 15, 2005
Strategies for national health care systems in emerging countries: the case of screening and prevention of renal disease progression in BoliviaNorberto Perico, Raul Plata, Agustina Anabaya, et al.
Lancet (London, England)|May 22, 2002
Combined kidney and liver transplantation for familial haemolytic uraemic syndromeGiuseppe Remuzzi, Piero Ruggenenti, Daniela Codazzi, et al.
Diabetes Care|January 28, 2003
Renal and metabolic effects of insulin lispro in type 2 diabetic subjects with overt nephropathyPiero Ruggenenti, Claudio Flores, Claudio Aros, et al.
Pageof 77